A detailed history of Transamerica Financial Advisors, Inc. transactions in Novo Nordisk A S stock. As of the latest transaction made, Transamerica Financial Advisors, Inc. holds 897 shares of NVO stock, worth $78,370. This represents 0.01% of its overall portfolio holdings.

Number of Shares
897
Previous 1,721 47.88%
Holding current value
$78,370
Previous $246,000 56.5%
% of portfolio
0.01%
Previous 0.03%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$119.07 - $145.42 $98,113 - $119,826
-824 Reduced 47.88%
897 $107,000
Q1 2024

May 15, 2024

SELL
$102.11 - $135.92 $696,083 - $926,566
-6,817 Reduced 79.84%
1,721 $221,000
Q4 2023

Feb 12, 2024

BUY
$87.78 - $105.45 $737,527 - $885,990
8,402 Added 6177.94%
8,538 $884,000
Q3 2023

Nov 14, 2023

BUY
$90.94 - $199.54 $12,367 - $27,137
136 New
136 $13,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $197B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Transamerica Financial Advisors, Inc. Portfolio

Follow Transamerica Financial Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Transamerica Financial Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Transamerica Financial Advisors, Inc. with notifications on news.